Parakeet Health Raises $10M to Scale Patient-Access AI

Patient demand can already exist while the appointment never does. A call goes unanswered, a referral sits in a fax queue, a cancellation stays open, or a patient drops out between one channel and the next.

Parakeet Health announced an oversubscribed $10M Series A on October 1, 2026, to build a more connected operating layer across those patient-access handoffs. Canvas Ventures led the financing, with Blank Space Ventures, StoryHouse Ventures, and HMC INQ participating, bringing the company's reported total funding to $13M.

The round matters because healthcare AI is moving beyond whether software can answer a phone call. The harder business question is whether one system can follow patient demand across voice, text, email, web, and fax, then complete the scheduling and follow-up work that turns demand into care.

What Happened

Parakeet Health says its annual recurring revenue grew 10x over the past year. The company now works with six of the 10 largest U.S. dermatology groups, supporting more than 2,800 providers across 1,100+ locations. Those figures come from Parakeet's announcement and are not independently audited, but they describe a company that has moved beyond an early voice demo into multi-location enterprise deployments.

Canvas Ventures led the Series A. The new capital follows Parakeet's $3M seed announcement in October 2024, when the company publicly introduced a voice platform for scheduling, insurance verification, patient intake, and inbound and outbound calls. The product has since expanded into a broader patient-access platform.

Parakeet plans to use the Series A to expand its technology and team, improve personalization, support larger enterprise customers, and move into additional specialties and patient-engagement workflows. The company did not disclose a valuation or individual investor check sizes.

Patient Access Is an Operating System Problem

Parakeet combines inbound calls, proactive outreach, fax processing, web scheduling, voice, SMS, email, and follow-up in one platform. The practical idea is that a referral arriving by fax should be able to trigger patient outreach, scheduling, and follow-up without becoming a new manual project at every handoff.

That sounds straightforward until the platform meets the operating reality of a medical group. Different providers perform different procedures, accept different insurance plans, work at different locations, and maintain different scheduling rules. The software must connect to EHR and practice-management systems, interpret those constraints, identify capacity, and complete the right action for the right patient.

Parakeet also uses a performance-based commercial model tied to results such as appointments booked, interactions resolved, and revenue generated. That pricing choice puts the company closer to the operating economics of its customers, where an unanswered call or unused appointment slot is both an access problem and a margin problem.

Why Dermatology Became the First Proof Point

Dermatology gives Parakeet a concentrated version of the patient-access challenge. Large groups manage recurring visits, many providers, multiple locations, procedure-specific rules, cancellations, no-shows, and demand that can exceed available appointment supply.

The company's Qualderm partnership makes that operating model more concrete. Qualderm supports nearly 160 practices across 17 states, and the deployment is designed to identify open capacity and reconnect patients after cancellations, missed visits, or overdue follow-up. Parakeet says it now serves six of the 10 largest dermatology groups, including three of the top five.

Parakeet also reports a 2.3x resolution rate in a head-to-head pilot against an unnamed AI voice vendor. Across deployments, the company reports up to 4.9x higher rebooking rates for no-shows and up to 4.2x higher rebooking rates for cancellations versus unnamed patient-engagement vendors. Those are company-reported comparisons, so the important evidence is the combination of disclosed methodology limits, named enterprise relationships, and continued deployment scale.

The Founding Team Matches the Workflow

Parakeet's founding team combines healthcare operations with product and engineering. Jung Park, co-founder and CEO, spent more than 25 years in healthcare operations and held leadership roles at One Medical, Epocrates, and California Skin Institute. Aaron Lee is co-founder and CTO, while Eric Mao is co-founder and CPO.

That mix matters because healthcare workflow software is often won or lost in exceptions. A clean demonstration may show an agent booking an appointment, but an enterprise deployment has to account for provider preferences, insurance nuances, procedure rules, multiple locations, patient history, and the unwritten operating knowledge held by experienced staff.

The company is also hiring across engineering, implementation, customer success, and recruiting, which aligns with its stated plan to expand both the technology and the team. Enterprise growth will require more than model performance; it will require deployment discipline and customer teams that can translate local operating rules into repeatable systems.

What the Series A Must Prove

Parakeet is expanding beyond dermatology into primary care, behavioral health, women's health, eyecare, physical therapy, gastroenterology, and radiology. Each specialty carries a different mix of scheduling logic, referral paths, recurring-care patterns, buyer priorities, and patient communication needs.

The Series A gives Parakeet room to turn a strong dermatology footprint into a broader healthcare platform. Its challenge is to preserve deep workflow customization while making deployment repeatable enough to support many specialties and large organizations.

Patient access is becoming a test of whether healthcare AI can own an outcome instead of one conversation. Parakeet's next deployments will show how far a unified system can travel before specialty-specific complexity demands a new set of operating decisions.